Metrix Biotech is headquartered in Colorado, USA. The company adheres to international standards and provides one-stop solutions for customers in the field of peptide drugs. It offers new peptide drugs, generic peptide drugs, complete sets of peptide impurities, technical development for consistency evaluation, and international registration services. To meet the needs of customers in new drug development, impurity research, and quality improvement, the company provides customized services for high-end peptide products, including drug peptide impurities, intermediates, peptide fragments, process development for peptide new drugs, and product customization. GMP-level peptide drug application and production services can also be provided according to customer product development requirements. Currently, the mature products include: linalopeptide, somatrope, pacanopeptide, carbenidrine, ziconotide acetate, octreotide, digaricar, ganiracetam, vasopressin, leuprorelin, etabanthine, desheprin, gonarelin, shemerlin, alarilin, teriparatide, liraglutide, pralinepeptide, cestreluk, growth hormone, cestreluk, iparilin, atobisabin, lanreotide, edoxetron, exenatide, terlipressin, abaric, goserelin, lisinopril, desmopressin, bivalirudin, triptorelin